Paid Clinical Trials Portland

Discover 998 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 998

AspirinUsing Aspirin to Improve Immunological Features of Ovarian Tumors

Recruiting

EARLY_PHASE1

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Portland OR, Charlottesville VA, Fairfax VA, Tampa FL

Code:

NCT05080946

Conditions

Ovarian Cancer

Fallopian Tube Cancer

Peritoneal Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Aspirin 325mg

Placebo

MRI AssessmentQuantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Location:

Portland OR, Seattle WA, Iowa City IA

Code:

NCT05704062

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Diffusion Weighted Imaging

Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Observational StudyRural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT06461962

Conditions

Methamphetamine Use

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Treatment as Usual

Telehealth-Cardiology

Crenolanib vs. MidostaurinStudy of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

PHASE3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Portland OR, Sacramento CA, Duarte CA, Los Angeles CAshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

Skeletal Muscle PerfusionSkeletal Muscle Perfusion With LVAD

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT02105831

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Contrast ultrasound skeletal muscle perfusion imaging

MetforminMetformin Use in Patients Undergoing Total Joint Replacement Surgery

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT06280274

Conditions

Hyperglycemia

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Metformin

Placebo

Biofeedback-Based RehabilitationWearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR, Salt Lake City UT, San Antonio TX

Code:

NCT06381674

Conditions

Mild Traumatic Brain Injury, Concussion

Rehabilitation

Balance Impairment

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback

Vestibular therapy for mTBI

IbrutinibA Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Portland OR, Vancouver WA, Eugene OR, Seattle WAshow 29 more

Code:

NCT05963074

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Venetoclax

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Portland OR, Vancouver WA, Clackamas OR, Oregon City ORshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

VP-001MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

Recruiting

PHASE1

Sponsor:

PYC Therapeutics

Location:

Portland OR, Dallas TX, Houston TX, Ann Arbor MIshow 1 more

Code:

NCT06455826

Conditions

Retinitis Pigmentosa 11

Retinal Degeneration

Eye Diseases

Retinal Disease

Retinal Dystrophies

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

VP-001